Cannabinoids for Chemotherapy-induced Nausea and Vomiting: Overview of Systematic Reviews

Crooked Bear Creek Organic Herbs

Chemotherapy-induced nausea and vomiting (CINV), one of the most distressing chemotherapy-related adverse events (AEs), affects about 75% of patients undergoing chemotherapy. Antiemetic drugs are considered first-line treatments, while cannabinoids are considered an option to be used if other antiemetics fail. The cannabinoids used for CINV include tetrahydrocannabinol (THC) and analogs of THC. The US Food and Drug Administration (FDA) approved the first synthetic cannabinoid as a prescription drug for the treatment of CINV in 1986. [Note: Dronabinol, synthetic THC (Marinol) was approved in 1986, not 1985 as the text states, as a schedule II drug. In 1999, the Drug Enforcement Administration (DEA) transferred it from schedule II to schedule III. Non-synthetic THC (i.e., the kind in the plant) remains a DEA schedule I drug (no medical use).] In this overview, the authors summarize evidence from and critique the quality of published systematic reviews (SRs) of cannabinoids in CINV.

CINAHL, Cochrane Database…

View original post 448 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s